Original Research
Accepted on 07 Apr 2025
Efficacy and safety of Rituximab for Membranous nephropathy in adults: A meta-analysis of RCT
in Glomerular disease
Frontiers in Nephrology
doi 10.3389/fneph.2025.1548679
- 255 views
Type at least 3 characters
31 articles
Case Report
Published on 01 Apr 2025
Case Report: a novel variant in WT1 leads to focal segmental glomerulosclerosis and uterovaginal anomalies through exon skipping
in Glomerular disease
Frontiers in Nephrology
doi 10.3389/fneph.2025.1542475
- 394 views
Original Research
Accepted on 26 Mar 2025
Real-world Challenges Associated with the Use of Four Common Systemic Glucocorticoids in a United States IgAN Cohort
in Glomerular disease
Frontiers in Nephrology
doi 10.3389/fneph.2025.1574239
Review
Published on 04 Feb 2025
The road ahead: emerging therapies for primary IgA nephropathy
in Glomerular disease
Frontiers in Nephrology
doi 10.3389/fneph.2025.1545329
- 3,038 views
Brief Research Report
Published on 23 Jan 2025
Global and national public awareness and interest in glomerular diseases from 2004 to 2024
in Glomerular disease
Frontiers in Nephrology
doi 10.3389/fneph.2025.1519481
- 1,268 views
Review
Published on 23 Dec 2024
Vascular injury in glomerulopathies: the role of the endothelium
in Glomerular disease
Frontiers in Nephrology
doi 10.3389/fneph.2024.1396588
- 1,551 views
Editorial
Published on 12 Dec 2024
Editorial: Insights in glomerular disease
in Glomerular disease
Frontiers in Nephrology
doi 10.3389/fneph.2024.1480968
- 627 views
Brief Research Report
Published on 31 Oct 2024
Increased levels of antibodies to synaptopodin and annexin 1 in patients with primary podocytopathies
in Glomerular disease
Frontiers in Nephrology
doi 10.3389/fneph.2024.1471078
- 750 views
Review
Published on 29 Oct 2024
C3 glomerulopathy: a kidney disease mediated by alternative pathway deregulation
in Glomerular disease
Frontiers in Nephrology
doi 10.3389/fneph.2024.1460146
- 2,525 views
Original Research
Published on 21 Oct 2024
The clinical course of SARS-CoV-2 infection in patients with glomerular diseases and evaluation of the subsequent risk of relapse
in Glomerular disease
Frontiers in Nephrology
doi 10.3389/fneph.2024.1472294
- 724 views
Editorial
Published on 11 Sep 2024
Editorial: IgA nephropathy: a nephrologist’s challenge in 2023
in Glomerular disease
Frontiers in Nephrology
doi 10.3389/fneph.2024.1477350
- 1,093 views
Review
Published on 06 Aug 2024
Evidence based treatment for lupus nephritis: present perspectives and challenges
in Glomerular disease
Frontiers in Nephrology
doi 10.3389/fneph.2024.1417026
- 3,361 views
Brief Research Report
Published on 30 Jul 2024
Lupus nephritis kidney biopsy characteristics and preterm birth
in Glomerular disease
Frontiers in Nephrology
doi 10.3389/fneph.2024.1402597
- 912 views
Original Research
Published on 11 Jul 2024
Relapse treatment with low-dose steroids in steroid-sensitive minimal change disease
in Glomerular disease
Frontiers in Nephrology
doi 10.3389/fneph.2024.1426156
- 1,652 views
Original Research
Published on 02 Jul 2024
Examining the role of patient-reported external factors and risk of relapse in anti-neutrophilic cytoplasmic autoantibody vasculitis
in Glomerular disease
Frontiers in Nephrology
doi 10.3389/fneph.2024.1404451
- 958 views
Review
Published on 04 Jun 2024
Lupus nephritis: management challenges during pregnancy
in Glomerular disease
Frontiers in Nephrology
doi 10.3389/fneph.2024.1390783
- 7,364 views